Caprylates: Clinical Trials

4 trials of Caprylates, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4

Follow Caprylates: new trials by email Literature Review of Caprylates trials Research Report on Caprylates

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Pharmacokinetics, Safety, and Tolerability of IGSC 20% in Subjects With Primary Immunodeficiency
IGSC 20% - Primary Immunodeficiency
Phase 3CompletedGrifols Therapeutics LLC612016-06-012020-06-16
Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency
IGIV-C 10%, IGSC 20% - Primary Immunodeficiency
Phase 3CompletedGrifols Therapeutics LLC532016-01-012019-10-04
Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified, Albumin (Human) 25%, United States Pharmacopeia (USP) - Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Phase 3CompletedGrifols Therapeutics LLC1172004-04-012016-03-23
Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified, Dextrose, 5% in Water - Immunologic Deficiency Syndrome, Agammaglobulinemia
Phase 3CompletedGrifols Therapeutics LLC1002002-08-012009-09-25

Conditions studied

Primary Immunodeficiency Diseases (3)  ·  Agammaglobulinemia (1)  ·  Common Variable Immunodeficiency (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)  ·  Severe Combined Immunodeficiency (1)  ·  Wiskott-Aldrich Syndrome (1)

Sponsors

Grifols Therapeutics LLC (4)

Countries

Canada (3)  ·  United States (3)  ·  Czechia (2)  ·  Germany (2)  ·  Poland (2)  ·  Argentina (1)  ·  Australia (1)  ·  France (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Mexico (1)  ·  Serbia (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Erwin Gelfand, MD (1)  ·  Norman Latov, MD (1)

Results publications

PMID 18178525, PMID 19260050, PMID 19365055, PMID 19496683, PMID 20457948, PMID 20647554, PMID 20837852, PMID 31621458

NIH funding

2015 (1)